Company / Free Cash Flow
Prime Medicine, Inc. Free Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$130.2M
FY2024
5-year range
-$174.1M / -$6.2M
FY2020-FY2024
Trend
+25.3%
vs FY2023
Sector context
#125 of 195
Health Care
What the data says
At -$130M, Prime Medicine, Inc.'s free cash flow ranks #125 of 195 in the Health Care sector. Free Cash Flow returned to growth in FY2024 after 3 years of decline, reaching -$130M.
Based on SEC 10-K filings.
-$130M in FY2024.
Improved from -$148M to -$130M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 195 in Health CareTop 64% of 195This company -$130.2M Sector average $465.6M
▼
-128.0% below sector average
Key checks
Key Insights
- In FY2024, free cash flow increased 25.3% year-over-year.
- Ranks #125 out of 195 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$130.2M | +25.3% |
| FY2023 | -$174.1M | -17.7% |
| FY2022 | -$147.9M | -286.9% |
| FY2021 | -$38.2M | -518.3% |
| FY2020 | -$6.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026